This page shows the latest QuintilesIMS news and features for those working in and with pharma, biotech and healthcare.
Firm will focus on human data science solutions. A year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA. ... Bousbib added: “We launched as QuintilesIMS, then we built something transformational and that
formulation making $700m in that period, according to QuintilesIMS data.
Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by personalised medicines, particularly in oncology. ... There will be a full report on QuintilesIMS' Question
Combined will be second-largest outsourcing provider after QuintilesIMS. Contract research organisation INC Research and commercial services firm InVentiv Health are to combine to create the second largest biopharmaceutical outsourcing provider.
As QuintilesIMS’ report into the core challenge of multichannel marketing - Channel Preference Versus Promotional Reality - points out, the traditional sales rep model that has disappeared in many other industries remains strong
Will collaborate with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer. QuintilesIMS has teamed up with four big pharma firms to gather insights into the real-world use of oncology therapies ... Currently, treatment-use information in Europe is based
More from news
Approximately 4 fully matching, plus 4 partially matching documents found.
Also speaking at the QuintilesIMS’ The Future of Pharma and Life Sciences in the UK debate was Ben Howlett. ... For QuintilesIMS’ general manager UK and Ireland, Tim Sheppard, the publication of a life science sector’s strategy that pulls together
This is underscored by research from analysts QuintilesIMS stating, notably, that biosimilars have increased patient access by 44% overall in the EU5 nations.
As a recent report on the global medicines outlook through 2021 from the QuintilesIMS Institute noted: 'Payers and providers are developing tools to better assess value and will demand, or create
opportunity. QuintilesIMS (2016).
opportunity. QuintilesIMS (2016).
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
QuintilesIMS. Neil Johnson, director, RJW, said: “We are delighted that Cathy is joining us, and we look forward to further expanding the RJW senior team as we develop our health care
Muhsin joins from QuintilesIMS Health, where he was therapy lead, oncology and prior to that he was a senior market analyst at Roche.
Waiton has held several roles at QuintilesIMS, serving there as regional business manager, national sales manager and hospital sales manager.
Jones previously worked for a variety of biotech, pharma and service companies including Novlion Therapeutics (formerly QLT), QuintilesIMS (formerly IMS Health) and Envision Pharma Group, where she was involved in publication
Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Prior to that he worked for QuintilesIMS, which is now IQVIA, in multiple senior consulting roles.
In this category we were up against competition from Blue Latitude Health, CE Consultancy, Cogora, MSD, QuintilesIMS, Sanofi and Teva.
She joins emotive. after 7 years at QuintilesIMS where she was most recently a Product &Strategy Director developing medical communications across a wide range of therapeutic areas.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
No results were found
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...